Table 1.
Total Sample | Doctor Only | BRENDA | CBT | |
---|---|---|---|---|
n=194 | n=64 | n=67 | n=63 | |
% Male | 74.2% | 78.1% | 73.1% | 71.4% |
% Caucasian* | 76.2% | 78.1% | 84.9% | 65.1% |
% Married | 32.3% | 33.3% | 39.4% | 23.8% |
% Naltrexone | 46.9% | 51.6% | 46.3% | 42.9% |
Mean Age | 43.7 (10.9) | 42.6 (11.4) | 44.3 (10.0) | 44.2 (11.2) |
Mean Years Education | 13.8 (2.7) | 13.5 (2.8) | 14.2 (2.6) | 13.7 (2.6) |
Mean BDI Score | 19.9 (10.2) | 19.1 (10.5) | 18.7 (9.2) | 22.1 (10.7) |
Mean Years of Lifetime Use (ETOH) | 23.3 (10.6) | 23.1 (11.5) | 22.9 (10.1) | 23.9 (10.3) |
Mean Days Used in the Past 30 (ETOH) | 19.2 (8.4) | 19.1 (7.9) | 18.4 (8.5) | 20.0 (8.9) |
p < 0.05; % Caucasian is greater in BRENDA than CBT.